The Viresolve Pro+ Solution virus filter is designed to fit both monoclonal antibody and therapeutic protein processes. Features of the Viresolve Pro+ Solution virus filter include a proprietary binary gas integrity test to detect the presence of oversized pores or defects which can compromise a filter’s retention capability and cause contamination in the end product.

Jean-Paul Mangeolle, president of Millipore’s Bioprocess Division said: “Virus safety is an increasingly critical issue in the biopharmaceutical industry and recent incidents of viral contamination have highlighted why effective virus safety solutions are so important for our customers. The launch of Viresolve Pro+ Solution expands our industry-leading virus safety offerings, which help company’s address increasingly diverse and difficult virus-removal challenges, improve the productivity of their manufacturing processes, and ensure the safety and quality of their products.”